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       INTRODUCTION 
Intravenous regional anaesthesia is a method of producing analgesia and muscle 
 relaxation of the distal part of a limb by intravenous local anaesthetic injection 
 while circulation to the limb is occluded. 
           Intravenous regional anaesthesia was discovered by August Bier, 
professor of surgery in berlin in 1908. To administer intravenous anaesthesia he 
occluded  the circulation in a segment of the arm with two tourniquets and then 
injected a solution of 0.5% procaine into a vein in the isolated segment. This 
technique was revived by Holmes in 1963, who used lignocaine because it 
appeared to give more reliable anaesthesia than procaine. Currently, intravenous 
regional anaesthesia sometimes referred to as Bier’s block is regarded as one of 
the several alternative techniques for arm anaesthesia. 
          Various drugs such as procaine, prilocaine, lignocaine, bupivacaine has 
been used in intravenous regional anaesthesia. Among these, lignocaine is the 
drug commonly used. As lignocaine does not have post tourniquet deflation 
analgesia other local anaesthetic dugs have been tried to improve the duration 
and post operative analgesia. 
        A longer acting agent bupivacaine initially gained substantial popularity 
but was laden with potentially serious side effects. Bupivacaine has been 
identified as a fast-in, slow-out type of local anaesthetic that maintains high 
affinity and binds tightly to myocardial sodium receptors. Therefore, if high 
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plasma concentrations of bupivacaine are achieved irreversible cardiac arrest 
may occur. 
       The amide local anaesthetic ropivacaine  is a pure -s- enantiomer and is 
structurally related to bupivacaine. The duration of effect of  ropivacaine is 
almost similar to that of bupivacaine . Ropivacaine has been shown to result in 
less depression of the cardiac conduction system when compared with 
bupivacaine. 
        Intravenous ropivacaine, compared with bupivacaine and lignocaine in 
several studies has less cardiac and central nervous system side effects but has 
achieved better surgical anaesthetic conditions. 
        In an attempt to reduce the amount of local anaesthetic required or to  
improve the quality of the block or both, various additives such as opiods, 
muscle relaxants, alpha2 agonists have been tried in intravenous regional 
anaesthesia with various results. Among these fentanyl a synthetic opiod is used 
in this study along with ropivacaine. 
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AIM OF THE STUDY 
 
The aim of the study is to evaluate, 
1)  the anaesthetic effects of  0.2% ropivacaine  
2) to compare it with the addition of fentanyl 50 mics 
 in intravenous regional anaesthesia.  
 The anaesthetic efficacy regarding, 
1) onset of sensory block 
2) onset of motor block  
3) occurrence of tourniquet pain 
4) duration of post op analgesia 
5) side effects, if any 
            are noted and compared. 
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ANATOMY OF SUPERFICIAL VENOUS SYSTEM OF UPPER LIMB    
     The venous supply of the upper limb is arranged in two planes, which are  
separated by superficial aponeurosis. The superficial venous system is used for  
intravenous regional anaesthesia. The local anaesthetic is injected into this  
 venous system and it is transported through a venous network into veins inside 
nerve trunks.  
      The dorsal digital veins converge to form three dorsal metacarpal veins that 
are interlinked to each other.The palmar digital veins drain into a dense vascular  
network on the palmar face of the hand and also into the dorsal veins by way of  
intercapillary veins. Most of the superficial veins join to form two large veins,  
the  cephalic vein and the basilic vein. An accessory cephalic vein is often 
present. Hence by this venous network, the local anaesthetic is transported into  
veins inside nerve trunks. 
     The cephalic vein is the preaxial vein of the upper limb. It begins from the  
lateral end of the dorsal venous arch. The cephalic vein runs upward the root of  
anatomic snuff box, and winds around the lateral border of the dorsal forearm. 
 In the proximal part of the forearm the cephalic vein runs medially to run along  
the anterior aspect of the forearm.  
       At the level of elbow, it runs between the tendons of brachioradialis and the  
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biceps brachii,crosses the lateral cutaneous nerve of forearm and then runs 
along the lateral border of biceps.It then pierces the deep fascia at the lower 
border of pectoralis major and then runs in the deltopectoral groove upto the 
infraclavicular fossa where it pierces the clavipectoral fascia and joins the 
axillary vein. 
     The accessory cephalic vein, when present arises from a venous network on 
the back of the forearm or from the lower part of cephalic vein. It joins the 
cephalic vein below or in front of the elbow. When the main cephalic vein 
drains into the basilic vein, the accessory cephalic may follow the course of the 
former above the elbow. 
    The basilic vein is the postaxial vein of the upper limb and arises from the  
medial end of the dorsal venous arch a little below the limb. It runs upward 
along the back of the medial border of the forearm, winds around this border to  
reach the ventral aspect of cubital fossa and then runs along the medial aspect of  
biceps brachii upto the middle of the arm, pierces  the deep fascia and runs 
along the medial side of the brachial artery,upto the lower border of the teres  
major where it continues as axillary vein. About 2.5cm above the medial 
condyle of the humerus, the basilic vein is joined by the medial cubital vein. It  
is accompanied by the posterior branch of medial cutaneous nerve of the 
forearm and the terminal part of the dorsal branch of ulnar nerve. The 
superficial palmar venous network is drained by the median vein of forearm, 
which runs along the anterior aspect of the forearm, in front of the elbow, it  
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drains directly into the basilic vein. 
    Hence the nerve endings in the skin are easily reached by the local 
anaesthetic solution through these valveless venules. The superficial veins are 
essentially that collapse when theirlumen are not filled with blood. The thick 
outermost layer of a vein is made of connective tissue called tunica adventitia or 
tunica externa. Deeper are bands of smooth muscle called tunica media, which 
are in general is thin, as it does not function in a contractile manner. The interior 
is  lined with endothelial cells called tunica intima. 
    The arterial system is the higher pressure portion of the circulatory system.  
systemic arteries can be divided into two types – muscular and elastic according  
to the relative composition of elastic and muscle tissue in their tunica media as  
well as their size and the make up of the internal and external elastic lamina. It  
is composed of three layers tunica adventitia, tunica media. Hence arteries are  
not easily collapsed when tourniquet is applied. 
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ANATOMY OF THE NERVE 
Neurons in human central nervous system are in many different size and shapes.  
These cells have five to seven processes called dendrites that extend outward  
from the cell body and arborize extensively. A typical neuron also has a long  
fibrous axon that originates from a thickened area of cell body called  axon 
hillock.The first portion of axon is called  initial segment.The axon divides into 
terminal segments ending in a number of synaptic knobs. 
              The axons are wrapped by a sheath of myelin ,the protein rich complex  
produced by Schwann cells. The myelin sheath envelops the axon except at the  
ending of node of Ranvier , a periodic 1 –micro metre constriction that are 
about 1 mm apart.  
     In intravenous regional anaesthesia, the initial effect being the blockade of  
peripheral small nerves and nerve endings. Block of large nerves at a proximal  
site (eg.cubital region in intravenous regional  nerve block of the arm), as well  
as via intraneural venous distribution of the local anaesthetic solution also 
occurs. Then during compression of the tourniquet, ischaemia occurs leading to 
blockade of nerve conduction . 
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ROPIVACAINE 
Ropivacaine hydrochloride, which is a member of the amino amide class of 
 local anesthetics. It is a sterile, isotonic solution that contains the 
enantiomerically pure drug substance, sodium chloride for isotonicity and water  
for injection. Sodium hydroxide or hydrochloric acid may be used for pH 
adjustment. 
Ropivacaine HCl is chemically described as S-(-)-1-propyl-2',6'-
pipecoloxylidide hydrochloride monohydrate8. The drug substance is a white 
crystalline powder, with a molecular formula of C17H26N2O•HCl•H2O, 
molecular weight of 328.89 and the following structural formula: 
 
At 25°C ropivacaine HCl has a solubility of 53.8 mg/mL in water, a distribution  
ratio of 14:1between n-octanol and phosphate buffer at pH 7.4 and a pKa of  
8.07 in 0.1 M KCl solution. The pKa of ropivacaine is approximately the same 
 as bupivacaine (8.1) and is similar to that of mepivacaine (7.7). However, 
ropivacaine has an intermediate degree of lipid solubility compared to 
bupivacaine and mepivacaine. 
Ropivacaine Injection is preservative-free and is available in single dose 
containers in 2mg/ml (0.2%), 5mg/ml (0.5%), 7.5mg/ml (0.75%) and 10 mg/mL  
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(1%) concentrations. The specific gravity range from 1.002 to 1.005 at 25°C. 
When prolonged blocks are used, either through continuous infusion or through  
repeated bolus administration, the risks of reaching a toxic plasma concentration  
or inducing local neural injury must be considered.  
     Reactions to ropivacaine are characteristic of those associated with other 
amide-type local anesthetics. A major cause of adverse reactions to this group 
of drugs may be associated with excessive plasma levels, which may be due to  
overdosage, unintentional intravascular injection or slow metabolic degradation. 
Systemic Reactions 
The most commonly encountered acute adverse experiences that demand 
immediate countermeasures are related to the central nervous system and the  
cardiovascular system. These adverse experiences are generally dose-related 
and due to high plasma levels that may result from overdosage, rapid absorption  
from the injection site, diminished tolerance or from unintentional intravascular 
injection of the local anesthetic solution. Factors influencing plasma protein 
binding such as acidosis, systemic diseases that alter protein production or 
competition with other drugs for protein binding sites, may diminish individual 
tolerance. 
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Neurologic Reactions 
    These are characterized by excitation and/or depression. Restlessness, 
anxiety, dizziness, tinnitus, blurred vision or tremors may occur, possibly 
proceeding to convulsions. However, excitement may be transient or absent, 
with depression being the first manifestation of an adverse reaction. This may 
quickly be followed by drowsiness merging into unconsciousness and 
respiratory arrest. Other central nervous system effects may be nausea, 
vomiting, chills, and constriction of the pupils. 
      The incidence of convulsions associated with the use of local anesthetics 
varies with the route of administration and the total dose administered. In a 
survey of studies of epidural anaesthesia, overt toxicity progressing to 
convulsions occurred in approximately 0.1% of localanaesthetic 
administrations. 
      The incidence of adverse neurological reactions associated with the use of 
local anaesthetics may be related to the total dose and concentration of local  
anaesthetic administered and are also dependent upon the particular drug used,  
the route of administration, and the physical status of the patient. Many of these  
observations may be related to local anaesthetic techniques, with or without a  
contribution from the drug.  
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Cardiovascular System Reactions 
     High doses or unintentional intravascular injection may lead to high plasma  
levels and related depression of the myocardium, decreased cardiac output, 
heart block, hypotension, bradycardia, ventricular arrhythmias, and possibly 
 cardiac arrest . 
Allergic Reactions 
     Allergic type reactions are rare and may occur as a result of sensitivity to the  
local anaesthetic.These reactions are characterized by signs such as urticaria, 
pruritus, erythema, angioneurotic edema (including laryngeal edema), 
tachycardia, sneezing, nausea, vomiting, dizziness, syncope, excessive 
sweating, elevated temperature, and possibly  anaphylactoid symptomatology 
(including severe hypotension). Cross-sensitivity among members of the amide-
type local anesthetic group has been reported. The usefulness of screening for 
sensitivity has not been definitively established. 
         In human volunteers given intravenous ropivacaine the mean (min-max)  
maximum tolerated total and free arterial plasma concentrations were 4.3 (3.4 to  
5.3) and 0.6 (0.3 to 0.9) mcg/mL Clinical data from patients experiencing local  
anaesthetic-induced convulsions demonstrated rapid development of hypoxia,  
hypercarbia and acidosis within a minute of the onset of convulsions. These 
observations suggest that oxygen consumption and carbon dioxide production 
are greatly increased during local anaesthetic induced convulsions and 
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emphasize the importance of immediate and effective ventilation with oxygen 
which may avoid cardiac arrest. 
Pharmacokinetics: Absorption 
      The systemic concentration of ropivacaine is dependent on the total dose 
and concentration of drug administered, the route of administration, the patient's  
hemodynamic/circulatory condition, and the vascularity of the administration 
site . From the epidural space, ropivacaine shows complete and biphasic 
absorption. The half-lives of the 2 phases, (mean ± SD) are 14 ± 7 minutes and  
4.2 ± 0.9 h, respectively. The slow absorption is the rate limiting factor in the  
elimination of ropivacaine that explains why the terminal half-life is longer after  
epidural than after intravenous administration. Ropivacaine shows dose-
proportionality up to the highest intravenous dose studied, 80 mg,corresponding  
to a mean ± SD peak plasma concentration of 1.9 ± 0.3 mcg/ml. 
            In some patients after a 300 mg dose for brachial plexus block, free 
plasma concentrations of ropivacaine may approach the threshold for CNS 
toxicity. At a dose of greater than 300 mg, for local infiltration, the terminal 
half-life may be longer ( > 30 hours). 
Metabolism 
     Ropivacaine is extensively metabolized in the liver, predominantly by 
aromatic hydroxylation mediated by cytochrome P4501A to 3-hydroxy 
ropivacaine. After a single intravenous dose, approximately 37% of the total 
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dose is excreted in the urine as both free and conjugated3-hydroxy ropivacaine. 
The N-de-alkylated metabolite of ropivacaine (PPX) and 3-OH-ropivacaine are 
the major metabolites excreted in the urine during epidural infusion.  
Elimination: 
    The kidney is the main excretory organ for most local anaesthetic 
metabolites. In total, 86% of the ropivacaine dose is excreted in the urine after 
intravenous administration of which only 1% relates to unchanged drug. After 
intravenous administration, ropivacaine has a mean ± SD total plasma clearance 
of 387 ± 107 mL/min, an unbound plasma clearance of 7.2 ± 1.6 L/min, and a 
renal clearance of 1 mL/min. The mean ± SD terminal half-life is 1.8 ± 0.7 h 
after intravascular administration . 
Pharmacodynamics: 
     Systemic absorption of local anaesthetics can produce effects on the central 
nervous and cardiovascular systems. At blood concentrations achieved with 
therapeutic doses, changes in cardiac conduction, excitability, refractoriness, 
contractility, and peripheral vascular resistance have been reported. Toxic blood  
concentrations depress cardiac conduction and excitability, which may lead to 
atrioventricular block, ventricular arrhythmias and to cardiac arrest, sometimes  
resulting in fatalities. In addition, myocardial contractility is depressed and 
peripheral vasodilation occurs, leading to decreased cardiac output and arterial 
blood pressure. 
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       Following systemic absorption, local anaesthetics can produce central 
nervous system stimulation, depression or both. Apparent central stimulation is 
usually manifested as restlessness, tremors and shivering, progressing to 
convulsions, followed by depression and coma, progressing ultimately to 
respiratory arrest. However, the local anaesthetics have a primary depressant 
effect on the medulla and on higher centers. The depressed stage may occur 
without a prior excited stage. 
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FENTANYL 
Fentanyl is a synthetic phenylpiperidine opiod of the 4-anilopiperidine series 
which is structurally related to pethidine. Commercially, fentanyl is formulated 
as a citrate available as an aqueous solution without preservatives. Each ml 
contains a base of 50 mcg of fentanyl. 
PHYSICOCHEMICAL PROFILE 
  Molecular weight                            528.29 
  Pka                                                 8.4 
  % unionized at pH 7.4                     8.5% 
  % bound to plasma proteins             84% 
   Potency                                          80 times  more potent than morphine 
 
PHARMACODYNAMICS 
 Analgesia  
          Analgesia results from action of fentanyl on opiod mu receptors both 
supraspinally in the brain and in the spinal cord. Intravenous fentanyl produces 
 analgesia at plasma concentrations between 0.6 – 3 ng/ml. 
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Cardiovascular system 
          Arterial blood pressure, cardiac output and pulmonary vascular resistance  
remains unchanged even after large doses of intravenous fentanyl. Fentanyl like 
other opiod agonists causes bradycardia that responds to intravenous atropine. 
Peripheral vasodilatation is much lesser than morphine due to absence of 
histamine release. 
Respiratory system 
         Fentanyl causes direct dose related respiratory depression due to its effect 
on medullary respiratory centre manifested as decreased sensitivity to carbon 
dioxide and reduced respiratory rate. This is typically seen when plasma 
concentrations exceed  > 2 ng/ml. The degree of respiratory depression is 
affected by various factors such as type of surgery, age and individual 
pharmacodynamic response. 
Central nervous system 
       Fentanyl causes less sedation than equianalgesic doses of morphine. In 
doses of 10 mcg/kg it causes dose related reduction in cerebral blood flow and 
CMRO2. Muscle rigidity probably reflects a manifestation of a catatonic state, a 
basic pharmacological property of opiods, related to enhancement of dopamine 
biosynthesis in the caudate nucleus.    
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Gastrointestinal tract 
            Fentanyl decreases gastrointestinal motility, increases intrabiliary 
pressure and causes a varying degree of nausea and vomiting. The vomiting is 
mediated via stimulation of the chemoreceptor zone in the area postrema.  
Genitourinary system 
             Like other opiods, fentanyl causes relaxation of detrusor muscle and 
increase in the urethral sphincter tone leading to urinary retention. This is 
probably not dose related and is more common with central neuraxial 
administration. 
PHARMACOKINETICS 
              Fentanyl is a potent opiod, highly lipophilic, producing a rapid onset of 
action of relatively short duration. After intravenous administration fentanyl is 
rapidly distributed to brain, heart and other highly perfused tissues. It also 
crosses the placental barrier easily. Peak effect occurs in 5 minutes. Within a 
short time the drug redistributes to the inactive tissue sites such as skeletal 
muscle and fat, associated with decrease in plasma concentration of drug, thus 
terminating its effect. About 75% of initial dose undergoes firstpass pulmonary 
uptake. When low doses are administered , redistribution terminates the effect 
and the drug appears short acting. With administration of large intravenous 
doses or continuous infusion, progressive saturation of inactive tissue sites 
occurs. 
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Pharmacokinetic profile 
Volume of distribution at steady state                          335 litres 
Clearance                                                                      1530 ml/min 
Effect-site equilibrium time                                           6.8 min 
Hepatic extraction ratio                                                0.8-0.1 
Context sensitive half time (4hrs infusion)                   260 mins 
Elimination half time                                                    3.1 to 6.6 hrs 
Metabolism 
         Fentanyl is biotransformed in the liver to inactive metabolites, primarily 
norfentanyl and several hydroxylation products. Only 4-7% of drug is excreted 
unchanged in the urine. Elimination half time of fentanyl is longer than 
morphine due to its high lipid solubility. Elimination half time is prolonged in 
elderly patients. A high hepatic extraction ratio means that the clearance of 
fentanyl is limited by hepatic blood flow. 
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INTRAVENOUS REGIONAL ANAESTHESIA 
When general anaesthesia is contra indicated, regional would be a better 
approach. One such regional anaesthetic technique used in upper limb surgeries 
is intravenous regional anaesthesia. This technique was chosen for this study 
considering the following merits . 
Merits: 
 1. Simple technique  
 2. Reliable and effective when properly used. 
 3. Rapid onset of action. 
 4. Rapid and prompt recovery from tourniquet release. 
 5. Good analgesia and adequate muscle relaxation. 
 6. Provides bloodless operative field. 
 7. Widely applicable to patients of different ages and physical status. 
Contraindications: 
1. Patient refusal 
 2. Absence of resuscitative equipments and drugs. 
 3. Allergy to local anaesthetics 
 4. Infection and cellulitis in the limb to be blocked 
 5. Conditions precluding use of tourniquet like 
 a. scleroderma  
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 b. hemolytic diseases such as sickle cell anaemia, thalassemia 
 c. Raynaud’s disease 
 d. malignancy 
 6. Lengthy procedure  
7. Patients with seizure disorders or with cardiac disorders. 
                        
PHARMACOKINETIC ASPECTS OF INTRAVENOUS REGIONAL 
ANAESTHESIA 
The exact mechanism of analgesia and muscle paralysis produced by this 
technique is not clear. It has been suggested that large venous channels that 
surround the nerve provide access for the drug to the vascular channels in the  
core of nerves. 
SITE OF ACTION : 
  The site and mode of action of the drug is still controversial. The  three most  
probable sites of action are  
 a.The sensory nerve endings 
 b.The neuromuscular junction 
 c.The nerve trunks. 
 According to ADAMS ET AL (1964) the anaesthetic solution a far more  
effective when placed into the isolated vascular tree rather than in the tissues at  
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random. By this method, the capillaries perform an important function in the 
production of anaesthesia by transporting lignocaine very effectively to both 
large and small nerves.This would explain the rapid decrease in the large nerve 
conduction speed as well as peripheral anaesthesia which first appears close to 
the point of injection.Since lignocaine is effectively shut off from the general 
circulation, it does not reach the liver and is not destroyed thereby providing 
anaesthesia as long as it is trapped in the arm. On release of tourniquet the 
remaining solution seems to be very rapidly flushed out of the extremity.The 
pharmacoaspects of intravenous regional anaesthesia have been described by 
TUCKER &BOAS (1971). They described that after cuff release, the peak 
plasma concentration of lignocaine were 20-80 % less than when a same dose of 
lignocaine is injected by direct intravenous route. The peak level achieved was 
inversely proportional to total time of the tourniquet applied. 
C.J.EVANS ET AL (1974) studied the duration of residual anaesthesia 
following release of tourniquet after intravenous anaesthesia. They found that 
the duration of block was related to duration action of the drugs when used 
clinically.With intravenous regional anaesthesia, the ability of the drug to 
remain in sufficient quantities to cause blockade of the neural transmission is 
important with regard to residual anaesthesia. As the drug reaches the nerve 
tissue by vascular channels and not by penetrating the nerve sheath , the 
duration of residual anaesthesia was found to be longest with ropivacaine and 
shortest with prilocaine. Both the safety and efficacy of the procedure depend 
on the interruption of the blood flow to the involved limb. Prolongation of the 
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tourniquet inflation time allows more local anaesthetic to be bound to tissues 
and thus, peak plasma concentration decrease proportionally with duration of 
the tourniquet time.After a tourniquet time of 10 minutes  about 30% of the 
lignocaine dose is released immediately in the first flush of blood after the 
deflation of the cuff .After 30 minutes about 45% of the dose still  remains in 
the arm.  
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MATERIALS AND METHODS 
This study was conducted in 50 patients undergoing hand surgeries in KAPV 
Govt medical college hospital. After getting institutional ethical committee 
approval and after explaining the procedure in detail , informed consent 
obtained from every patient. The patients were assigned into two groups  each 
containing 25 patients.  
GROUP 1:  Patients in this group received 40 ml of 0.2 % ropivacaine 
GROUP 2:  Patients in this group received 40 ml of 0.2 % ropivacaine with 
fentanyl 50 mics 
SELECTION OF PATIENTS 
 The patients selected for this study were of ASA I and II, undergoing 
elective hand surgeries where the expected duration is less than an hour. 
EXCLUSION CRITERIA : 
  Patients with history of any cardiovascular , respiratory or central nervous  
system disorders were excluded from the study. Patients with haematological 
disorders like sickle cell anaemia and thalassemia, patients with known 
hypersensitivity to  ropivacaine ,patients with difficult airway , were also 
excluded from the study. 
 
 
 
29 
 
PREANESTHETIC ASSESSMENT 
 Physical status of all the patients were pre-operatively  assessed. A 
thorough airway assessment was done. The following investigations were done 
on all the patients. 
 1. Hemoglobin 
 2. Urine analysis 
 3. Blood sugar 
 4. Blood urea and serum creatinine 
 5. Chest x - ray 
 6. Electrocardigram 
RESUSCITATIVE MEASURES 
 The following equipments and drugs were kept ready to meet any  
emergency. 
 1. Boyle’s apparatus 
 2. Laryngoscope with appropriate size blades 
 3. Endotracheal tubes of various sizes and connectors 
 4. Suction apparatus 
5. Drugs like anticonvulsants, antihistamines, vasopressors, steroids and  
         bronchodilators. 
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PROCEDURE 
 The patients were shifted into the operation theatre. The pulseoximeter,  
non-invasive blood pressure monitor and electrocardiographic monitor were 
connected to the patient. The vital parameters were recorded. A separate 
intravenous line was started in the non- operated limb. A vein in the dorsum of 
the hand of the operated limb was cannulated with 22G intravenous cannula. If 
the dorsum of the hand was involved in the surgery, a vein higher up in  the 
forearm was chosen . It was firmly fixed , flushed with normal saline and 
stopper applied.  
           Exsanguination was accomplished by elevation of  the limb for 5 minutes  
followed by use of esmarch bandage from fingertip to arm. In subjects where 
application of esmarch bandage was not feasible, emptying of veins was 
facilitated with compression of axillary artery with the limb elevated3. At the 
proximal end of the esmarch bandage, the first tourniquet was applied around 
the upper part of the arm over cotton wool padding. Then the tourniquet was 
inflated to 250 mmHg. Circulatory isolation of the arm was verified by 
inspection, absence of radial pulse and loss of pulseoximeter tracing of the 
ipsilateral index finger. Then 40ml of local anaesthesia solution was injected 
through the cannula at a rate of 1ml/second.  
 After ensuring complete analgesia below the first tourniquet, the second 
tourniquet was applied distal to the first tourniquet and inflated to 250mmHg.  
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The first tourniquet was then removed. The patients were observed for any  
toxic manifestations of local anaesthetics after release of the first tourniquet.  
The following parameters were recorded. 
Time of onset of sensory block: 
  It is the time elapsed from injection of study drug to sensory block  
achieved in all dermatomes of the operated limb. This was checked by pinprick  
every minute till the onset of sensory block 
Time of onset of motor block: 
 It is the time elapsed from injection  of  the study drug to the inability of  
voluntary movements in the operated limb. This was checked by asking the 
patient to flex the elbow and hand every minute till the onset. 
Incidence of tourniquet pain: 
        Intraoperative tourniquet pain, if perceived was noted and documented. 
Time of sensory block recovery (post op analgesia): 
 It is the time elapsed from tourniquet deflation to recovery of pain (VAS 
> 5) in all dermatomes of the operated limb. 
Side effects: 
       Side effects after tourniquet release, if any was noted and documented.  
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ASSESSMENT OF PAIN 
       Pain is a personal, subjective experience . There are three  major 
psychological dimensions of pain sensory –discriminative, motivational-
affective and cognitive-evaluative. These categories of activity interact with one  
another to provide perceptual information on the location, magnitude and 
spatiotemporal properties of the noxious  stimuli:motivational tendency towards  
escape or attack ; and cognitive information based on past experience. All three  
forms  of activity could then influence motor mechanisms responsible for the  
complex pattern of overt responses that characterize pain. 
           Pain assessment should be ongoing, individualized and documented. The  
measurement of pain is important : to determine pain intensity, perception 
qualities  and  duration, to aid in diagnosis, to help decide on the therapy and to  
evaluate the relative effectiveness of different therapies. 
           Pain is subjective; changes in pain over time are difficult to interpret and  
have probably  different meaning  to each individual and  there is no way to 
objectively quantify it. So the patient’s self report provides the most valid  
measure  of the experience. The ideal pain measure should be  sensitive, 
accurate ,reliable, valid and  useful for both clinical and experimental conditions  
and should be able to separate the sensory aspects of pain from the emotional  
aspects.  
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Visual Analogue Scale(VAS): 
     VAS  is most commonly a straight 100-mm line, that has the the words “no  
pain” at the left most end and “worst pain imaginable” at the right most 
end.Patients are instructed to place  a mark on the line indicating the amount of  
pain that they feel  at the time of evaluation.The distance of this mark from the  
left end is then measured, and this number is used as a numeric representation  
of the patient’s pain. 
 no pain                                                                             worst imaginable pain    
Advantages: 
  1. Sensitive to changes in a pain experience. 
  2. Its ease and brevity of administration and scoring. 
  3. Relatively easy to understand for most patients. 
  4. Its minimal intrusiveness. 
  5. Its greater sensitivity to detect intervention-based changes in pain.  
 
Disadvantages: 
1. Its attempt in assigning a single value to a complex, multidimensional  
experience. 
2. Assesses only one dimension(intensity)  of a complex experience. 
3. Has a ceiling at the upper most end .      
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OBSERVATION AND RESULTS 
Table 1    
AGE DISTRIBUTION 
Mean age in years in group 1 is  35.20 ± 8.431 
Mean age in years in group 2 is  37.70 ± 7.929 
Table 2 
    SEX DISTRIBUTION 
 
 
                                
Age distribution in years Group 1 Group 2 
   20 -30 
   30-40 
   40-50 
    >50 
     6 
    12 
     6 
     1 
    5 
   14 
    4 
    2 
 
   Total 25 25 
Sex Group 1 Group 2 
Male 
Female 
18 
7 
16 
9 
Total 25 25 
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Table  3 
    WEIGHT DISTRIBUTION 
 
Weight in kgs Group 1 Group 2 
<50 
50-60 
>60 
6 
14 
5 
5 
10 
10 
Total  25 25 
 
Mean weight(kgs) in group 1 is 55.00 ± 6.843 
Mean weight(kgs) in group 2 is 58.12 ± 6.629 
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Table 4 
  TIME OF ONSET OF SENSORY BLOCKADE 
 
Time of onset of sensory  
block in minutes 
Group 1 Group 2 
< 5 
5 -7  
>7  
0 
8 
17 
 
3 
17 
5 
 
Meantime of sensory block onset in group 1 is 7.88 ± 1.363 
Meantime of sensory block onset in group 2 is 6.24 ± 1.714  
The meantime required for onset of sensory block in group 1 was more than  
group 2.  
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Table 5     
TIME OF ONSET OF MOTOR BLOCK 
 
 
 
 
 
 
Meantime of onset of motor block in group 1 is 11.8 ± 1.825 
Meantime of onset of motor block in group 2 is 9.88 ± 1.691 
The mean time required for onset of motor block was more in group 1 than 
group 2. 
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Table 6 
INCIDENCE OF TOURNIQUET PAIN DURING 
I NTRAOPERATIVE PERIOD 
   
Tourniquet time in 
minutes 
Group 1 Group2 
5 0 0 
10 0 0 
15 1 0 
20 2 0 
30 1 0 
40 0 0 
 
No of patients perceived tourniquet pain in group 1 is 4. In group 2 there  
was no incidence of tourniquet pain. 
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Table 7 
   TOTAL DURATION OF SURGERY 
Total duration of surgery 
in minutes 
Group 1 Group 2 
<30 
30-40 
40-50 
>50 
10 
12 
3 
0 
11 
7 
6 
1 
Meantime of surgery(min) in group 1 is 30.6 ± 10.033 
Meantime of surgery(min) in group 2 is 31.36 ± 11.365 
Table 8 
   TOTAL DURATION OF TOURNIQUET 
Total duration of 
tourniquet in minutes 
Group1 Group 2 
30-40 
40-50 
>50 
 
19 
5 
1 
 
18 
4 
3 
Meantime of duration of tourniquet (min) in group 1 is 37.4 ± 7.921 
Meantime of duration of tourniquet (min) in group 2 is 38.00 ± 9.574 
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Table 9 
VARIATIONS IN BLOOD PRESSURE AND HEART RATE AFTER 
TOURNIQUET RELEASE 
 % of variation in blood pressure Group 1 Group 2 
0 – 10% 
10 – 20% 
>20% 
16 
3 
4 
21 
2 
1 
Mean % of variation in rise in blood pressure in group 1 is 9.24 ± 8.664 
Mean % of variation in rise in blood pressure in group 2 is 6.87 ± 4.559 
Two patients in group 1 and one patient in group 2  had fall in blood pressure 
after tourniquet release. 
Table 10 
% increase in heart rate Group 1 Group 2 
0 – 10% 
10 – 20% 
>20% 
16 
5 
4 
15 
7 
3 
Mean %  of increase in heart rate in group 1 is 9.34 ± 9.472 
Mean % of increase in heart rate in group 2 is 10.39 ± 8.118 
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Table 11 
 
DURATION OF POST OPERATIVE ANALGESIA ( VAS>5 ) 
 
 
 
Meantime of post operative analgesia in group 2 is more than group 1. 
 
 
 
 
 
 
 
Group Meantime and standard deviation of post op analgesia 
(mins)  
Group 1 
Group 2 
120.76 ± 20.755 
137.52 ± 24.036 
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Table 12 
SIDE EFFECTS 
Side effects Group 1 Group 2 
Tinnitus 
Light headedness 
Perioral numbness 
Vomiting  
Nausea 
dizziness 
Vertigo 
Skin rashes 
Arrhythmias 
convulsions 
0 
2 
0 
0 
0 
1 
0 
0 
0 
0 
0 
1 
0 
1 
2 
0 
0 
0 
0 
0 
 
Incidence of side effects in both groups are nearly same. Incidence of nausea 
and vomiting was slightly higher in group 2. 
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      DISCUSSION 
 
 Demographic profile                              
 Group 1 Group 2  p value 
Age  35.20 ± 8.431 37.70 ± 7.929  
< 0.05 
 
Weight  55.00 ± 6.843 58.12 ± 6.629 
Sex ( m:f ) 18:7 16:9 
 
The demographic profile of both groups is comparable. The difference between 
both the groups is statistically not significant. 
   
 Group 1 Group 2 p value 
Duration of surgery (mins) 30.6 ± 10.033 31.36 ± 11.365 0.803 
Duration of tourniquet (mins) 37.4 ± 7.921 38.00 ± 9.574 0.810 
 In our study, there was no significant difference between the two  
groups for blood pressure, pulse rate during preoperative and intraoperative  
time. Meantime of duration of surgery and tourniquet duration of both groups 
showed no significant difference. 
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 Group 1 Group 2 p  value 
Onset of sensory block (mins) 7.88 ± 1.363 6.24 ± 1.714 < 0.05 
Onset of motor block (mins) 11.8 ± 1.825 9.88 ± 1.691 <0.05 
 
        In our study, the sensory block onset time was quicker in ropivacaine plus 
fentanyl group(6.24+/-1.714min) when compared to ropivacaine group (7.88 +/-
1.363 min)and this was statistically significant. (p value 0.0005- independent 
sample test). These values were  consistent with the findings of T.T.Nieme et al 
(2006). 
       The onset time of motor block also more in ropivacaine group (11.8 ± 1.825 
min ) when compared to ropivacaine with fentanyl group ( 9.88 ± 1.691 min ). 
This was statistically significant. (p value = 0.0003 - paired t test). This finding 
correlated with the results of Noelle hua lim et al, 1999. They found that the 
addition of fentanyl and mivacurium to the prilocaine enhances the onset of 
motor blockade. 
     Iurie Acalovschi et al studied the effect of meperidine alone in intravenous 
regional anaesthesia. They concluded that the use of meperidine in IVRA 
developed sensory and motor block, demonstrating the local anesthetic action of 
the drug. The motor-blocking activities were more marked than the 
sensoryblocking activities.   
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      Pang et al. in  their study demonstrated the effect of tramadol in intravenous 
regional anaesthesia. They were able to induce a sensory block to pinprick, 
touch and cold at the intradermic injection site of 5% tramadol similar to that of 
1% lidocaine. The suggested site of action of tramadol was the nerve endings 
and a possible associated central effect of tramadol was excluded because of the 
small doses used (25 mg).  In our study, fentanyl a synthetic opiod also lowered 
the onset time of sensory and motor block when it was added to ropivacaine 
when compared to ropivacaine alone. 
 
 Group 1 Group 2 p value 
% variation in rise in blood 
pressure 
9.24 ± 8.664 6.87 ± 4.557 0.675 
% of increase in heart rate 9.34 ± 9.472 10.39 ± 8.118 0.245 
 
       The hemodynamic variations after tourniquet release were minimal in both 
the groups and the difference between the both groups is insignificant.  
(p value >0.05). 
      In our study the incidence of tourniquet pain is higher in ropivacaine group. 
4 patients in ropivacaine group perceived intra operative tourniquet pain while 
this was nil in patients who received fentanyl along with ropivacaine. This 
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finding correlated with the findings made by  Ibrahim Asif et al who compared 
ropivacaine 0.2% and lignocaine 0.5%. 
 
 Group 1 Group 2 p value 
 
Duration of post op analgesia 
(mins) 
 
120.76 ± 
20.755 
 
137.52 ± 
24.036 
 
0.011 
 
       The duration of post op analgesia was higher in ropivacaine plus fentanyl 
group (137.52 ± 24.036 min) when compared to ropivacaine group ( 120.76 ± 
20.755 min) and this difference was statistically significant. (p value is 0.011 - 
student paired t test). Lim and Ong, 2003 studied the effect of fentanyl with 
lignocaine and found post operative visual analog scores are significantly 
reduced in patients receiving  fentanyl 1 mic/kg. This finding also correlated 
with the results of Ashok kumar B Puttappa et al ,2010. 
       The incidence of side effects was similar in both the groups. Patients who 
received fentanyl along with ropivacaine showed higher incidence of nausea 
and vomiting when compared to ropivacaine group. This result is similar to that 
of M.T. Pikaknen, P.H. Rosenberg, 2007 who studied the effect of fentanyl 
along with prilocaine in intravenous regional anaesthesia and found that the 
incidence of nausea and vomiting is higher in fentanyl group.  
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SUMMARY 
We conducted a randomised control study in 50 ASA I and II patients aged 19 
to 60 for elective hand surgeries by intravenous regional anaesthetic technique 
at KAPV Govt medical college hospital, Trichy .  
This study was to evaluate the, 
1)  anaesthetic efficacy,  
2) post tourniquet release analgesia  
3) side effects of ropivacaine 0.2% alone and to compare it with adding 
fentanyl 50 mics. 
  The patients were divided into two groups namely group 1 and group 2.   
     1) Sensory block onset,  
     2)  motor block onset, 
     3) incidence of tourniquet pain, 
     4) post tourniquet release analgesia   
     5) side effects ,if any                        
              were evaluated. 
     We found that fentanyl 50 mics when added with ropivacaine 0.2% in 
intravenous regional anaesthesia improved the anaesthetic efficacy, lengthened 
post tourniquet analgesia and reduced the incidence of tourniquet pain as 
compared to Ropivacaine alone, which has been proved statistically significant  
using quantitative and qualitative analysis. 
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CONCLUSION 
 
 We conclude that ropivacaine 0.2%  with fentanyl 50 mics in intravenous 
regional anaesthesia has good anaesthetic efficacy, lengthened post operative  
analgesia and less incidence of intra operativetourniquet pain with minimal 
alterations in hemodyanamics after tourniquet release when compared to 
ropivacaine 0.2% alone. 
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and superior postoperative analgesia compared with 0.5% lidocaine when 
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2) Ropivacaine is effective for IVRA and improves postoperative analgesia. 
Muscle relaxants enhance the motor block and when combined with 
fentanyl allow for an equivalent quality of IVRA with 50% reduction in 
LA dose. Authors: Flamer D, Peng PW Published Date November 2011 
Volume 2011: 
3) Comparison of ropivacaine 2 mg ml−1 and prilocaine 5 mg ml−1 for i.v. 
regional anaesthesia in outpatient surgery  
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the median nerve ropivacaine plasma concentrations were markedly 
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Regional Anesthesia in Volunteers ,Maximilian W. B. Hartmannsgruber, 
MD*, ,David G. Silverman, MD*, Thomas M. Halaszynski, DMD, MD*, 
Vonda Bobart, MD September 1999 vol. 89 no. 3 727 , postdeflation 
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blockade in group L was 11.76.± 3.08 minutes , group F was 12.96±3.06 
minutes , and group P was 10.20±3.52 minutes which was clinically 
comparable in all the groups. However the time for onset of motor 
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compared to other two groups: group L (12.5±2.6minutes and group P 
(11.36±3.5 minutes).  
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A comparative study between 0.2% ropivacaine and 0.2% ropivacaine with 
fentanyl 50 mics in intravenous regional anaesthesia 
 
Name:                                       Age/Sex:                    Wt: 
IP no:                                         Address: 
 
 
Diagnosis:                                             Surgery:     
 
Group 1:  0.2% ropivacaine  40 ml 
Group 2:  0.2% ropivacaine  40 ml plus fentanyl 50 mics 
 
Tourniquet time:  Proximal- 
                                     Distal – 
Time for onset of sensory block: 
Time for onset of motor block: 
Incidence of intra op tourniquet 
                                                pain: 
Duration of sugery    : 
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Duration of tourniquet: 
 Duration of post op analgesia: 
 Side effects after tourniquet release: 
 
 
TOURNIQUET TIME 
 
 
      B.P 
 
    PULSE 
 
    SPO2 
 
SIDE 
EFFECTS 
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A comparative study of anaesthetic efficacy of 0.2% ropivacaine alone and 
0.2% ropivacaine with fentanyl 50 mics in intravenous regional anaesthesia 
Abstract of the study: 
      A longer acting local anaesthetic ropivacaine has been successfully used in 
intravenous regional anaesthesia. Fentanyl, a synthetic opiod in a dose of 50 mics 
was used along with 0.2% Ropivacaine in this study and the anaesthetic efficacy 
was compared with 0.2% ropivacaine alone. AIM OF THE STUDY: The 
anaesthetic efficacy regarding onset of sensory and motor block, incidence of 
intraoperative tourniquet pain, duration of post op analgesia, variation in 
hemodyanamics after tourniquet release and side effects, if any were noted and 
compared. MATERIALS AND METHODS: 50 patients of ASA 1,2 status 
undergoing elective hand surgeries were included in this study. They were 
randomly allocated into 2 groups. Group 1 received 40 ml of 0.2% ropivacaine 
alone. Group 2 received 40 ml 0.2% ropivacaine along with fentanyl 50 mics. 
Onset time of sensory and motor block, incidence of tourniquet pain, variations in 
heart rate and blood pressure after tourniquet release, duration of post op analgesia 
and side effects were noted. RESULTS: Both the groups were comparable with 
respect to demographic characteristics. Onset of sensory block (mins) in group 1 
was 7.88 ± 1.363 and in group 2 it was 6.24 ± 1.714 and this difference was 
statistically significant (p < 0.05). Onset of motor block in group 1 is 11.8 ± 1.825 
mins and in  group 2 9.88 ± 1.691. ( p < 0.05 ). Meantime of duration of surgery 
and tourniquet in both the groups showed no difference statistically. There was no 
significant difference in variations in hemodynamics after tourniquet release. Four 
patients in group 1 perceived intraoperative tourniquet pain and this was nil in 
patients who received fentanyl along with ropivacaine. The incidence of nausea 
and vomiting was present in patients who received fentanyl along with 
ropivacaine. Duration of post op analgesia (VAS > 5) in group 1 was 120.76 ± 
20.755 mins and in group 2 it was 137.52 ± 24.036 mins and this difference is 
statistically significant (p < 0.05). CONCLUSION:  We conclude that ropivacaine 
0.2%  with fentanyl 50 mics in intravenous regional anaesthesia has good 
anaesthetic efficacy, lengthened post operative  analgesia and less incidence of 
intra operative tourniquet pain with minimal alterations in hemodyanamics after 
tourniquet release when compared to ropivacaine 0.2% alone. 
    
    
DURATION DURATION ON TOUR RELEASE
SN NAME AGE SEX WT. kgIP NO DIAGNOSIS procedure SO MO SURGERY TOURNIQUETTOURNIQUET PAIN SYS BP PR BP PR VAR IN BP
VAR IN  
PR POST OP ANAL (mins)COMPLICATION
1 rajendran 33 M 56 34523 inj L hand tendon repair 9 11 35 40 130 82 140 83 7.69 1.21 120
2 marimuthu 38 M 45 37654 cut injury R hand tendon repair 8 12 40 45 128 88 132 90 3.12 2.27 148
3 ramasamy 45 M 45 21763 inj R thumb K wiring 6 13 20 30 118 79 128 82 8.47 3.79 140 dizziness
4 kokilavani 37 F 57 11123 ganglion l wrist excision 8 14 25 30 at 15 mins 122 86 142 86 16.39 0 96
5 arumugam 37 M 57 26713 imp dermoid excision 8 12 20 30 136 91 138 94 1.47 3.29 122
6 pattapan 47 M 58 20934 inj L hand excision 9 14 35 40 130 78 152 80 16.92 2.56 105
7 udhayadasan 38 M 46 13942 inj F4F5 WD &k  wiring 8 10 40 45 122 69 130 71 6.55 2.9 130
8 veerasamy 33 M 58 40651 cut injury R hand tendon repair 9 12 45 50 130 72 136 75 4.61 4.16 158
9 divakaran 28 M 64 51982 ganglion R hand excision 6 12 30 35 116 74 122 78 5.17 5.4 120
10 ranidevi 42 F 52 22981 ganglion L hand excision 7 11 25 30  112 80 142 98 26.78 22.5 135 light headedness
11 rajapandian 31 M 39 52349 inj F4F5 WD &k  wiring 9 14 45 50 132 92 110 98 -16.66 6.52 100
12 selvi 33 F 49 51897 cut injury R hand tendon repair 6 12 45 50 AT 20 mins 128 78 136 102 6.25 33.33 75
13 vijayakumar 26 M 54 49812 ganglion R hand excision 8 15 30 35 120 76 120 98 0 28.94 120
14 rajarajan 23 M 58 52076 inj L hand K wiring 9 14 15 30 136 68 138 76 1.47 11.76 145
15 mariappan 52 M 52 51555 ganglion L hand excision 6 10 20 30 140 81 124 82 -11.42 1.23 137 lightheadedness
16 arivoli 49 M 66 41423 inj L index WD &k  wiring 6 9 35 40 124 67 138 75 11.29 11.94 160
17 umar sheik 34 M 48 29123 cut injury R hand tendon repair 7 9 35 40 at 20 mins 122 76 156 87 27.86 14.47 112
18 abdul razak 45 M 54 25412 inj L hand excision 8 11 25 30 120 72 148 91 23.33 26.38 120
19 lakshmi 21 F 64 33345 finger nodule excision biopsy 8 11 20 30 128 79 132 85 3.12 7.6 116
20 amutha 24 F 59 18723 foreign body excision 11 13 30 35 132 82 136 96 1.51 17.07 98
21 velyudham 36 M 62 44456 imp dermoid excision 9 11 35 40 116 84 142 94 22.41 11.9 112
22 praveenbabu 32 M 64 54123 cts decompression 10 15 15 30 114 96 120 98 5.26 2.08 128
23 silambayee 31 F 58 28754 ganglion R hand excision 8 11 30 35 132 78 136 82 3.03 5.13 120
24 adithyan 24 M 53 45198 raw area finger flap cover 8 10 50 55 AT 30 mins 122 83 `124 84 1.64 1.2 90
25 rasathi 41 F 57 25681 ganglion l wrist excision 6 9 20 30 120 83 130 88 8.33 6.02 112
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1 selvakumari 31 F 56 10465 dermoid excision 8 9 25 30 118 78 128 83 8.47 6.41 130
2 aravanan 35 M 60 11234 ganglion R hand excision 7 11 25 30 120 72 132 88 10 22.22 160
3 subramani 54 M 49 23459 inj R thumb K wiring 6 10 35 40 102 86 112 96 9.8 11.62 142
4 chandra 36 F 55 45678 finger nodule excision biopsy 8 12 30 35 114 77 120 86 5.26 11.68 128
5 selvaraj 35 M 48 28934 imp dermoid excision 6 9 20 30 132 86 138 94 4.54 9.3 150 nausea, vomiting 
6 alagesan 42 M 70 34321 foreign body excision 6 11 30 35 128 74 136 78 6.25 5.4 140
7 veerapan 36 M 67 43214 lacerated wound  thumbsuturing 5 9 20 30 124 72 130 74 4.83 2.77 98
8 veerasamy 32 M 62 54378 cut injury R hand tendon repair 7 10 50 55 138 90 126 92 -8.69 2.22 128
9 mohanasundaram 37 M 48 743216 raw area finger ssg 6 8 30 35 126 79 128 89 1.58 12.65 148
10 alphonse 40 F 55 10621 ganglion L hand excision 7 11 15 30 138 81 132 88 4.34 8.65 140
11 sivakumar 36 M 64 12754 imp dermoid excision 5 8 35 40 130 90 132 98 1.53 8.88 168 dizziness
12 chitra 39 F 51 20954 cut injury R hand tendon repair 6 10 19 30 140 112 136 122 21.42 8.92 170
13 arumugam 29 M 59 34521 ganglion R hand excision 8 12 35 40 122 75 126 87 3.27 16 136
14 ramkumar 28 M 61 41754 inj L hand K wiring 4 9 30 35 124 68 130 77 4.83 13.23 180
15 arokiasamy 58 M 49 38943 trigger finger release 6 10 55 60 118 88 124 89 5.08 1.13 140 nausea, vomiting 
16 dhandapani 46 M 67 32786 inj L index WD &k  wiring 4 9 50 55 114 76 120 84 5.26 10.52 120
17 kannapiran 49 M 66 43768 cut injury R hand tendon repair 3 9 40 45 126 79 138 89 9.52 12.65 160
18 kumarasamy 43 M 49 43675 ganglion l wrist excision 11 14 15 30 122 81 136 88 11.47 8.64 120 nausea, vomiting 
19 neela 28 F 58 23908 cts decompression 5 7 25 30 130 85 140 87 7.69 2.35 100
20 mallika 27 F 55 32987 foreign body excision 6 8 25 30 124 68 130 94 4.83 38.23 90
21 ramasamy 36 M 65 42167 imp dermoid excision 9 13 45 50 114 80 130 99 14.03 23.75 120
22 selvam 36 F 64 23145 cts decompression 5 8 40 45 130 92 130 94 0 2.17 130
23 archana 39 F 57 20983 ganglion R hand excision 5 10 20 30 120 81 132 87 10 7.4 110
24 ravikumar 29 M 61 16792 cts decompression 7 11 45 50 122 78 130 84 6.55 7.69 160
25 neelaveni 42 F 57 13876 ganglion l wrist excision 6 9 25 30 134 91 140 96 4.47 5.49 170
